探索吸入皮质类固醇和面部衰老风险之间的潜在关联:孟德尔的随机化研究.
Junpeng Li1, Yaqiong Liu2, Gujie Wu2
1Department of Surgery Tohoku, University Graduate School of Medicine, Sendai 980-8575, Japan.
吸入性皮质类固醇 (ICSs) 可能通过影响ORMDL3基因表达和5-基代谢来加速面部衰老. 需要进一步的研究来证实这些对皮肤衰老的潜在影响.
科学领域:
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 喘影响全球超过3亿人,吸入性皮质类固醇 (ICS) 是主要治疗方法.
- 长期使用ICS可能会引起副作用,包括皮肤变化.
- 调查ICS与衰老之间的潜在联系至关重要.
研究的目的:
- 探索吸入性皮质类固醇 (ICS) 和面部衰老之间的潜在因果关系.
- 确定介导因素和遗传机制,将ICS与面部衰老联系起来.
- 调查ORMDL3基因表达和DNA甲基化在这种关联中的作用.
主要方法:
- 利用孟德尔的随机化 (MR) 和局部化分析与大规模的遗传和表型数据.
- 来自DrugBank,DGIdb,cis-eQTL,GWAS的面部衰老和血代谢的综合数据.
- 分析了DNA甲基化QTL (mQTL) 数据,以探索表观遗传调节.
主要成果:
- 核磁共振分析表明,遗传代理ICS (ORMDL3) 和欧洲人面部衰老之间存在显著的关联.
- 鉴定出5-基是ICS和面部衰老之间的关系中的潜在调解者.
- ORMDL3的新型DNA甲基化位点显示与面部衰老有类关联,这表明它们有调节作用.
结论:
- 研究结果表明,ICS可以通过ORMDL3上调和改变5-基素代谢来影响面部衰老.
- 这些结果假设一种新的机制将喘药物与皮肤衰老联系在一起.
- 需要进一步的药理和临床研究来验证这些探索性发现.
更多相关视频
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Bias in Epidemiological Studies
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
